Page last updated: 2024-12-11

beta-damascenone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

beta-damascenone: from Ipomoea pes-caprea; RN given refers to cpd without isomeric designation; RN 23726-93-4 refers to beta-damascenone; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

beta-damascenone : A cyclic monoterpene ketone that is 2,6,6-trimethylcyclohexa-1,3-diene substituted at position 1 by a crotonoyl group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

FloraRankFlora DefinitionFamilyFamily Definition
IpomoeagenusA plant genus in the family CONVOLVULACEAE best known for morning glories (a common name also used with CONVOLVULUS) and sweet potato.[MeSH]ConvolvulaceaeThe morning glory family of flowering plants, of the order Solanales, which includes about 50 genera and at least 1,400 species. Leaves are alternate and flowers are funnel-shaped. Most are twining and erect herbs, with a few woody vines, trees, and shrubs.[MeSH]

Cross-References

ID SourceID
PubMed CID5366074
CHEMBL ID3733030
CHEBI ID67251
SCHEMBL ID80947
MeSH IDM0203168

Synonyms (71)

Synonym
2-buten-1-one, 1-(2,6,6-trimethyl-1,3-cyclohexadien-1-yl)-
2-buten-1-one, 1-(2,6,6-trimethyl-1,3-cyclohexadien-1-yl)-, (e)-
.beta.-damascenone
damascenone, natural, 1.1-1.3 wt. % (190 proof ethanol), fg
damascenone
(e)-1-(2,6,6-trimethylcyclohexa-1,3-dien-1-yl)but-2-en-1-one
23696-85-7
A816852
4-(2,6,6-trimethyl cyclohexa-1,3-dienyl)but-2-en-4-one
2-buten-1-one, 1-(2,6,6-trimethyl-1,3-cyclohexadien-1-yl)-, (e)
u66v25tbo0 ,
unii-u66v25tbo0
(e)-1-(2,6,6-trimethyl-1,3-cyclohexadien-1-yl)-2-buten-1-one
2-buten-1-one, 1-(2,6,6-trimethyl-1,3-cyclohexadien-1-yl)-, (2e)-
einecs 245-844-2
trans-beta-damascenone
23726-93-4
beta-damascenone
LMPR01070304
1-[2,6,6-trimethyl-1,3-cyclohexadien-1-yl]-2e-buten-1-one
einecs 245-833-2
4-(2,6,6-trimethylcyclohexa-1,3-dienyl)but-2-en-4-one
fema no. 3420
damascenone (natural)
1-(2,6,6-trimethyl-1,3-cyclohexadien-1-yl)-2-buten-1-one
(2e)-1-(2,6,6-trimethylcyclohexa-1,3-dien-1-yl)but-2-en-1-one
beta-(e)-damascenone
(e)-beta-damascenone
trans-damascenone
CHEBI:67251
(2e)-1-(2,6,6-trimethyl-1,3-cyclohexadien-1-yl)-2-buten-1-one
AKOS015914961
.beta.-damascenone [mi]
(e)-.beta.-damascenone
damascenone,.beta.-
4-(2,6,6-trimethyl cyclohexa-1,3-dienyl) but-2-en-4-one [fhfi]
(e)-1-(2,6,6-trimethyl-1-cyclohexa-1,3-dienyl)but-2-en-1-one
.beta.-damascenon, trans-
trans-.beta.-damascenon
S6431
SCHEMBL80947
1-crotonoyl-2,6,6-trimethylcyclohexa-1,3-diene
2,6,6-trimethyl-1-crotonoyl-1,3-cyclohexadiene
damascenone, trans-
2,6,6-trimethyl-1-trans-crotonoyl-1,3-cyclohexadiene
(2 e)-1-(2,6,6-trimethylcyclohexane-1,3-dien-1-yl)but-2-en-1-one
trans-.beta.-damascenone
1-(2,6,6-trimethyl-1,3-cyclohexadien-1-yl)-2-buten-1-one, trans-
.beta.-(e)-damascenone
dtxsid6041397 ,
cas-23696-85-7
tox21_304001
dtxcid80196511
NCGC00357220-01
AC-34815
1-(2,6,6-trimethylcyclohexa-1,3-dien-1-yl)but-2-en-1-one
CHEMBL3733030
damascenone, analytical standard
damascenone, certified reference material, tracecert(r)
CS-0022815
HY-N2543
discontinued, unstable
Q416126
BS-16271
mfcd00101024
damascenone (e-beta)
(e)-1-(2,6,6-trimethylcyclohexa-1,3-dienyl)but-2-en-1-one
1-(2,6,6-trimethyl-1,3-cyclohexadien-1-yl)-2-buten-1-one; 1-(2,6,6-trimethyl-1,3-cyclohexadienyl)-2-buten-1-one; 1-crotonoyl-2,6,6-trimethyl-1,3-cyclohexadiene; 2,6,6-trimethyl-1-(2-butenoyl)-1,3-cyclohexadiene
2,6,6-trimethyl-1-crotonyl-1,3-cyclohexadiene
DTXSID90885242
?-damascenone, 90%
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
fragranceA substance, extract, or preparation for diffusing or imparting an agreeable or attractive smell.
volatile oil componentAny plant metabolite that is found naturally as a component of a volatile oil.
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
enoneAn alpha,beta-unsaturated ketone of general formula R(1)R(2)C=CR(3)-C(=O)R(4) (R(4) =/= H) in which the C=O function is conjugated to a C=C double bond at the alpha,beta position.
apo carotenoid monoterpenoid
cyclic monoterpene ketoneA cyclic terpene ketone in which the terpene specified is monoterpene.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (2)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
GLI family zinc finger 3Homo sapiens (human)Potency30.29790.000714.592883.7951AID1259369; AID1259392
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency8.63490.001530.607315,848.9004AID1224841
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1659751Agonist activity at TRPA1 (unknown origin) at 1000 uM relative to AITC2020Bioorganic & medicinal chemistry letters, 06-01, Volume: 30, Issue:11
Identification of a new class of non-electrophilic TRPA1 agonists by a structure-based virtual screening approach.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (71)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (2.82)18.2507
2000's22 (30.99)29.6817
2010's37 (52.11)24.3611
2020's10 (14.08)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 39.68

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index39.68 (24.57)
Research Supply Index4.28 (2.92)
Research Growth Index5.63 (4.65)
Search Engine Demand Index53.70 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (39.68)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews4 (5.63%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other67 (94.37%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]